Vimarsana
Biggest News Aggregation in the World

Page 2 - Michael Cogley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Cogley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Cogley Today - Breaking & Trending Today

What Happened to Hopin, the $7.8 Billion Virtual Events Unicorn - Vimarsana News

What Happened to Hopin, the $7.8 Billion Virtual Events Unicorn

Hopin, the virtual events startup, attained a wild $7.75 billion valuation when it was two years old. Now it's being carved up. What happened?

10 Things in Tech: Software's final chapter, $1,000 to scroll TikTok for 10 hours, and Tesla's first-ever ad - Vimarsana News

10 Things in Tech: Software's final chapter, $1,000 to scroll TikTok for 10 hours, and Tesla's first-ever ad

It's Tech Tuesday, buds. I'm Diamond Naga Siu, and I'm back home in San Diego (woah) after visiting New York. Big thanks to my brilliant colleagues Michael…

Source: biztoc.com
10 things in tech: Epstein appeared to threaten Gates, Apple gets its AI cut, and a Twitter hotel - Vimarsana News

10 things in tech: Epstein appeared to threaten Gates, Apple gets its AI cut, and a Twitter hotel

Welcome to Monday, folks. I'm Michael Cogley, a senior editor on the startups and venture capital team in London. Apple may not be the first mover in the…

Source: biztoc.com
10 Things in Tech: Epstein Threat to Gates, Apple's AI Cut - Vimarsana News

10 Things in Tech: Epstein Threat to Gates, Apple's AI Cut

In today's edition: Jeffrey Epstein appeared to threaten and try to blackmail Microsoft cofounder Bill Gates, Apple gets its AI cut, and a Twitter hotel.

10 Things in Tech: Remote Work Morally Wrong, BookTok a Kingmaker - Vimarsana News

10 Things in Tech: Remote Work Morally Wrong, BookTok a Kingmaker

In today's edition: Elon Musk on "morally wrong" remote work, TikTok assumes the role of literary kingmaker, and press releases get the AI treatment.